When Merck & Co launched the Advantage study in 1999, it said it was testing the painkiller, Vioxx, alongside its competitor. Internal company documents now show that the clinical trial was "masquarading as science" and was actually a marketing ploy designed to promote the use of Vioxx among doctors pre-market. Merck denies the allegations in this published study.